TOIIW
Oncology Institute, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.05
−3.27%Price chart
Jun 23Jun 26Jul 1Jul 7Jul 13Jul 22Jul 29Aug 3
Key dataAug 3, 2026
Open$0.05
From 52W high−81.69%
Volume5.00
Market cap$46.20M
P/E (TTM)—
P/S (TTM)0.1x
Div yield—
Key dataAug 3, 2026
Open
$0.05
From 52W high
−81.69%
Volume
5.00
Market cap
$46.20M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−5.0x
P/E (TTM)
—
RSI (14)
48.3
MomentumView details →
1D Return
−3.27%
YTD Return
−60.66%
SummaryUpdated Jun 1, 2026
The Oncology Institute, Inc. (NASDAQ:TOI) is a community-based oncology company founded in 2007 and headquartered in Cerritos, California. The company went public in June 2020 and has grown to become one of the largest value-based oncology providers in the United States. Operating 67 clinic locations across multiple states, TOI specializes in providing comprehensive cancer care services to adult and senior cancer patients through a network of over 100 specialty-trained physicians and healthcare providers.
Similar companies
Latest newsMore news →
Oncology Institute announced it has rebranded as Starling Oncology.44d agoOncology Institute, Inc. issued warrants exercisable for 10,025,535 shares of its common stock to Deerfield Partners, L.P. and affiliates, with an initial exercise price of $8.567 per share and expiration on August 9, 2027.75d ago